Predicting CAR-T cell Immunotherapy Success through ImmunoPET

Chimeric antigen receptor (CAR)-T cell therapy has generated unprecedented advances in the treatment of hematologic cancers, but readily translatable imaging approaches to visualize the in vivo dynamics of CAR-T cells are lacking. Noninvasive PET imaging is the ideal tool to monitor CAR-T cells.

Automated summary

CAR-T cell therapy has made unprecedented advances in treating hematologic cancers, but there is a lack of readily translatable imaging approaches to visualize the dynamics of CAR-T cells in vivo. Noninvasive PET imaging is considered the ideal tool for monitoring CAR-T cells.